RTM Vital Signs

RTM Vital Signs develops wearable and implantable medical devices for continuous real-time monitoring of critical health information—primarily focused on cardiovascular and respiratory health. Their lead products include an implantable cardiac monitor capable of measuring full blood pressure waveforms remotely during daily activities and a wearable wireless device for continuous respiratory function tracking. The technology aims to address major healthcare cost drivers such as opioid-induced respiratory depression in hospitals by enabling proactive intervention through AI-powered analytics. Animal studies have shown safety; human trials are being prepared.